In March 2025, the company announced new programs for just a direct-to-client supplying of its Wegovy weight loss drug. The company recognized a new pharmacy, referred to as NovoCare, which would demand clients $499 each month for use of the drug, below 50 percent the price of the drug via other pharmaceutical distribution networks.[53]to help you